All In Biotech

Free tool

FAERS Monitor: Marplan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011961 or its brand name (Marplan, Isocarboxazid). Reports on generic versions are filed under their own applications.

Reports

94

Serious

61

65% of reports

Hospitalization

27

Death reported

21

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • completed suicide17
  • drug ineffective14
  • insomnia10
  • toxicity to various agents10
  • dizziness7
  • serotonin syndrome7
  • stress cardiomyopathy7
  • malaise6
  • depression5
  • headache5
  • hyperhidrosis5
  • vision blurred5
  • weight increased5
  • blood pressure increased4
  • confusional state4

Reports by year received

View as table
YearReports
20044
20051
20062
20071
20093
20105
20112
20122
20134
20144
20155
20166
201712
201810
20191
20204
20213
20251
202624

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,065 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
stress cardiomyopathySignal7269.7132.21,613
serotonin syndromeSignal781.640.0480
completed suicideSignal1745.729.7701
toxicity to various agentsSignal1013.37.4102
hyperhidrosisSignal58.73.727
insomniaSignal108.44.759
vision blurredSignal58.13.525
blood pressure increasedSignal45.92.212
confusional stateSignal45.52.111
weight increasedSignal55.02.112
depressionSignal54.92.112
dizzinessSignal73.11.58
malaiseSignal63.11.47
drug ineffectiveSignal142.41.510
headache51.80.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.